Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration
暂无分享,去创建一个
Manuela Semmler-Behnke | Alexander Wenk | Ulrich Simon | Martin Schäffler | Wolfgang G Kreyling | W. Kreyling | U. Simon | J. Lipka | M. Semmler-Behnke | A. Wenk | G. Schmid | Stephanie Hirn | C. Schleh | Günter Schmid | Carsten Schleh | Stephanie Hirn | M. Schäffler | Jens Lipka | Manuela Semmler-Behnke | Jens Lipka
[1] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[2] Hiroyuki Ohshima,et al. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[3] G W Halbert,et al. The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.
[4] Jonathan S Dordick,et al. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[5] G Pohlmann,et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] Chun-Ting Kuo,et al. On the size evolution of gold-monolayer-protected clusters by ligand place-exchange reactions: the effect of headgroup-gold interactions. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[7] Wolfgang Kreyling,et al. Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.
[8] A. Gebert,et al. M cells in Peyer's patches of the intestine. , 1996, International review of cytology.
[9] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[10] M. Hashida,et al. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. , 1996, Journal of drug targeting.
[11] W. Saltzman,et al. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.
[12] Sabine Neuss,et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.
[13] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[14] Alexander T. Florence,et al. Utilizing Bacterial Mechanisms of Epithelial Cell Entry: Invasin-induced Oral Uptake of Latex Nanoparticles , 2004, Pharmaceutical Research.
[15] G. Schmid,et al. Tracer Diffusion of a Ligand-Stabilized Two-Shell Gold Cluster , 1996 .
[16] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[17] U. Bakowsky,et al. Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy , 2006, Pharmaceutical Research.
[18] J. Dordick,et al. Cytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. , 2009, Small.
[19] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[20] J. Seifert,et al. Intestinal absorption of macromolecules and small particles. , 1990, Digestive diseases.
[21] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[22] A T Florence,et al. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.
[23] R. Murray,et al. Reaction of Au(55)(PPh(3))(12)Cl(6) with thiols yields thiolate monolayer protected Au(75) clusters. , 2005, Journal of the American Chemical Society.
[24] Ravi S Kane,et al. Increasing protein stability through control of the nanoscale environment. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[25] R M Albrecht,et al. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.
[26] R. Murray,et al. Reaction of Au55(PPh3)12Cl6 with thiols yields thiolate monolayer protected Au75 clusters , 2005 .
[27] A. Florence,et al. Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.
[28] Sabine Neuss,et al. Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.
[29] P. Artursson,et al. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] Bengt-Harald Jonsson,et al. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[31] M. Rescigno,et al. Uptake and presentation of orally administered antigens. , 2005, Vaccine.
[32] K. Carr,et al. Factors influencing intestinal microparticle uptake in vivo. , 2007, International journal of pharmaceutics.
[33] M. Loeffler,et al. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.
[34] Monic Shah,et al. Biological applications of gold nanoparticles. , 2014, Journal of nanoscience and nanotechnology.
[35] Jack F Douglas,et al. Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.
[36] C. Lehr,et al. PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.
[37] J. Powell,et al. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. , 2010, Journal of autoimmunity.
[38] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[39] Pakatip Ruenraroengsak,et al. Nanosystem drug targeting: Facing up to complex realities. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[40] R. Samstein,et al. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. , 2008, Biomaterials.
[41] Yves-Jacques Schneider,et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[42] J. Seifert,et al. Rapid insorption of small particles in the gut. , 1990, The American journal of gastroenterology.
[43] N. Krug,et al. Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models , 2009, Inhalation toxicology.
[44] A. Konig,et al. [Blood volume of rat organs and residual amount of blood after blood letting or irrigation; determination with radiophosphorus-labeled erythrocytes]. , 1955, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.
[45] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[46] N Hussain,et al. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.
[47] U. Schumacher,et al. Uptake of inert microparticles in normal and immune deficient mice. , 2008, International journal of pharmaceutics.
[48] M. Morishita,et al. Effects of isoflurane on gastrointestinal motility after brief exposure in rats. , 2005, International journal of pharmaceutics.
[49] T. Fuchigami,et al. Electrochemical asymmetric reduction of prochiral carbonyl compounds, oximes, and a gem-dihalide on a poly-L-valine-coated graphite electrode. , 1983 .
[50] A. König,et al. Das Blutvolumen einiger Rattenorgane und ihre Restblutmenge nach Entbluten bzw. Durchspülung. Bestimmung mit P32-markierten Erythrocyten , 2004, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[51] Alexander T Florence,et al. Pharmaceutical nanotechnology: more than size. Ten topics for research. , 2007, International journal of pharmaceutics.
[52] A T Florence,et al. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[53] J. Seifert,et al. The influence of age and particle number on absorption of polystyrene particles from the rat gut. , 1996, Journal of anatomy.
[54] Mina Choi,et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.
[55] G. Schmid. The relevance of shape and size of Au55 clusters. , 2008, Chemical Society reviews.